Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Reviewarticle: Prevalence of Dysphonia in Patients With Covid-19: A Systematicreviewandmeta-Analysis Publisher



Aghaz A1 ; Shahriyari A2 ; Panahiaboozar S3 ; Jadidi H4 ; Khoshgoftar M5 ; Choupani E6 ; Hemmati E7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Psychology, School of Psychology and Educational Sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran
  3. 3. Department of Psychology, Faculty of Education and Psychology, University of Tehran, Tehran, Iran
  4. 4. Department of Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Health Education, Health Promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Iran
  7. 7. Candidate in Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Journal of Modern Rehabilitation Published:2022


Abstract

Introduction: This study aimed to estimate the prevalence of dysphonia in patients with COVID-19. Materials and Methods: English and Persian studies that reported dysphonia in patients with COVID-19 were included. Review and case report studies were excluded. We searched Web of Science, PubMed, Google Scholar, and Scopus from January 1, 2020, to July 15, 2021. The prevalence of dysphonia was obtained by combining the results and weighing the sample sizes in the corresponding studies. Heterogeneity was evaluated using the Cochran Q test and I2 Results: Of the 1830 articles identified, 7 studies (n=1410 patients) were included in the meta-analysis. The pooled prevalence of dysphonia was 31% (%95CI: 13%-48%). The prevalence rates of dysphonia in men and women with COVID-19 were 28.2% (%95CI: 14%-46%) and 32.8% (%95CI: 22%-45%), respectively. Conclusion: Because of the design of the included studies, the reliability of the results is limited. There was notable heterogeneity in the data, not because of publication bias, but rather the small sample sizes or the heterogeneity of the COVID-19 disease. About one-third of patients with COVID-19 may have dysphonia as the only symptom. Therefore, one should even be careful in approaching those who have only dysphonia. © 2021 The Authors.